Comorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across Europe LANCET REG HEALTH-EU
In Vitro Evidence of Therapy-Induced Suppression of Prothrombotic and Proinflammatory Phenotypes in Severe COVID-19 THROMB HAEMOSTASIS
European Expert Recommendations on Teclistamab Management for Relapsed or Refractory Multiple Myeloma CL LYMPH MYELOM LEUK
m-EASIX (better than EASIX) predicts severe CAR T-cell toxicities, worse overall survival, and discriminates cytokine release syndrome from sepsis Front Immunol